CTRI/2021/06/034469
Not yet recruiting
未知
Cardiovascular Manifestation In Moderate ToSevere COVID-19 Patients Undergoing Treatment InCritical Care Unit Of A Tertiary Care Hospital,West Bengal And Role Of Portable, Point Of CareCardiac Biomarker Autoanalyzer In Their EarlyDiagnosis.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- MEDICAL COLLEGE KOLKATA
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Laboratory confirmed COVID\-19 patients
- •Patients on different modalities of oxygen therapy
- •Patients with radiologically confirmed pneumonia
- •Suffering from ARDS / Acute Respiratory Failure
Exclusion Criteria
- •Patients unwilling to participate in the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Cardiovascular disease manifestations in COVID-19 patientsHealth Condition 1: B99-B99- Other infectious diseasesHealth Condition 2: B338- Other specified viral diseasesCTRI/2021/06/034065Dr Swati Datta
Completed
Not Applicable
Cardiac- and vascular disease (-abnormalities) as underlying cause of premature birth.premature birth100103941001027310003216NL-OMON39237Academisch Medisch Centrum300
Not yet recruiting
Not Applicable
Clinical outcomes and cardiovascular responses to High Intensity Interval Training versus Moderate Intensity Continuous Training in Heart Failure Patients: A randomized, controlled trial.Systolic Heart FailureCardiovascular - Other cardiovascular diseasesPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitationACTRN12612000511831niversity of New England48
Recruiting
Not Applicable
Cardiovascular Outcomes in Patients with Non-ST-Elevation Acute coronary syndrome with Negative Stress TestThe non-ST-elevation acute coronary syndrome (NSTE-ACS) patientsNon-elevation acute coronary syndrome1 year mortality rateCardiovascular OutcomesNegative Exercise stress testNegative Dobutamine stress echocardiography testTCTR20190118005Faculty of Medicine, Chiang Mai University265
Recruiting
Phase 3
ong term impact of RAS inhibition on cardio-renal outcomes: a comparative trial of angiotensin converting enzyme inhibitors, angiotensin receptor blockers or combined therapy with both agents in patients with one or more cardiovascular risk factors and microalbuminuria, diabetic or not diabetic.Patients with one or more cardiovascular risk factors and microalbuminuria, diabetic or not diabetic.Cardiovascular - Normal development and function of the cardiovascular systemMetabolic and Endocrine - DiabetesACTRN12607000333415Consorzio Mario Negri Sud2,100